CD83 and neoplasm: Among ovarian cancer cell subpopulations, CD83 transcript was significantly upregulated (logFC >2, p < 0.01) in EpCAM+CD45+ highly aggressive, drug-resistant, and ovarian cancer stem cell-containing tumor cells compared to EpCAM+ cells, as revealed by GSE75036 [43] (Figure S1).